Ranibizumab Injection - Accentrix Solution for Injection

1 Injection in 1 Packet Out of Stock

₹ 16772 ₹23960 30% OFF Save: ₹7188

1 INJECTION 1 Packet ₹ 16772 ₹23960 30% OFF Save: ₹7188

Out of Stock

Manufactured by: Novartis India Ltd
Contains / Salt: Ranibizumab (10 mg/ml)

Ranibizumab Benefits & Uses

Ranibizumab is used to treat the following -

Other Benefits

Diabetic Eye Disease
Macular Degeneration

Ranibizumab Dosage & How to Take

This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.

Find the right dosage based on disease and age

Age Group	Dosage
Adult	Disease: Macular Degeneration Before or After Meal: As advised by a physician Single Maximum Dose: 0.5 mg Dosage Route: Ophthalmic Frequency: doctor administered Course Duration: As directed by the doctor Special Instructions: Given once monthly, For course duration follow doctor's advice
Geriatric	Disease: Macular Degeneration Before or After Meal: As advised by a physician Single Maximum Dose: 0.5 mg Dosage Route: Ophthalmic Frequency: doctor administered Course Duration: As directed by the doctor Special Instructions: Given once monthly, For course duration follow doctor's advice

Ranibizumab Side Effects

Based on research, the following side effects have been observed when Ranibizumab is used -

Severe

Conjunctivital Hemorrhage
Increased Intraocular Pressure

Moderate

Eye Inflammation
Cataract
Constipation (Read More - Home remedies for constipation)
Conjuctival Hyperemia

Mild

Eye Pain
Pharyngitis
Cough
Sinus inflammation
Influenza like symptoms

Ranibizumab Related Warnings

Is the use of Ranibizumab safe for pregnant women?

Ranibizumab may have some side effects during pregnancy. Pregnant women should discontinue the use of Ranibizumab, and talk to their doctor, if they notice any discomfort.

Moderate
Is the use of Ranibizumab safe during breastfeeding?

Ranibizumab may have very limited harmful effects for breastfeeding women.

Mild
What is the effect of Ranibizumab on the Kidneys?

Using Ranibizumab does not have any harmful effects on kidneys.

Safe
What is the effect of Ranibizumab on the Liver?

Ranibizumab is completely safe for the liver.

Safe
What is the effect of Ranibizumab on the Heart?

You can take Ranibizumab without any fear of damage to the heart.

Safe

Severe Interaction of Ranibizumab with Other Drugs

Ranibizumab should not be taken with following medicines due to severe side effects it may cause to patients -

Moderate

Verteporfin

Ranibizumab Contraindications

If you are suffering from any of the following diseases, you should not take Ranibizumab unless your doctor advises you to do so -

Glaucoma
Eye Infections

Frequently asked Questions about Ranibizumab

Is this Ranibizumab habit forming or addictive?

No, you will not get addicted to Ranibizumab.

No
Is it safe to drive or operate heavy machinery when consuming?

No, you should not drive or operate heavy machinery after taking Ranibizumab as you may feel sleepy.

Dangerous
Is it safe?

Yes, but take Ranibizumab only as per medical advice.

Safe, but take only on Doctor's advise
Is it able to treat mental disorders?

No, Ranibizumab cannot treat any kind of mental disorder.

No

Ranibizumab Interactions with Food and Alcohol

Interaction between Food and Ranibizumab

Taking Ranibizumab with food is safe.

Safe
Interaction between Alcohol and Ranibizumab

Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Ranibizumab.

Unknown

See all substitutes for Ranibizumab

Lucentis Injection - ₹70160
Ranibizumab Injection - ₹70160
Accentrix Solution for Injection - ₹16772

This medicine data has been created by -

Vikas Chauhan

B.Pharma, Pharmacy
5 Years of Experience

References

US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lucentis® (ranibizumab)

In stock alternatives of Ranibizumab (based on Ranibizumab)